Stroke Alert September 2022

verona_stalcia

42 min•0 تشغيلات•0 مفضلات

Knowledge

الوصف

On Episode 20 of the Stroke Alert Podcast, host Dr. Negar Asdaghi highlights two articles from the September 2022 issue of Stroke: “<a href= "https://www.ahajournals.org/doi/10.1161/STROKEAHA.122.038650">Transdural Revascularization by Multiple Burrhole After Erythropoietin in Stroke Patients With Cerebral Hypoperfusion</a>” and “<a href= "https://www.ahajournals.org/doi/10.1161/STROKEAHA.121.036567">Silent Infarcts, White Matter Integrity, and Oxygen Metabolic Stress in Young Adults With and Without Sickle Cell Trait</a>.” She also interviews Dr. Timo Uphaus about his article “<a href= "https://www.ahajournals.org/doi/10.1161/STROKEAHA.121.037006">Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis</a>.” Dr. Negar Asdaghi: Let's start with some questions. 1) Can performing multiple burrholes improve misery perfusion in patients with moyamoya disease? And if yes, how do the results compare to that of a direct EC-IC bypass surgery? 2) The glycoprotein VI antagonist Revacept provides lesion-directed thromboinhibition at the site of atherosclerotic plaque rupture without causing systemic platelet inhibition. In other words, it works where it should work without causing the systemic side effects of antiplatelet therapies. Is Revacept the future of carotid-related stroke treatment? 3) And finally, how should we counsel the family members of a patient with sickle cell anemia who are found to have sickle trait carrier state? Is sickle cell trait a risk factor for development of ischemic stroke? We're back here with the Stroke Alert Podcast to answer these questions and cover the latest in Stroke because, without a doubt, this is the best in Stroke. Stay with us. Welcome back to another issue of the Stroke Alert Podcast. My name is Negar Asdaghi. I'm an Associate Professor of Neurology at the University of Miami Miller School of Medicine, and your host for the mo

المبدعون

darwin_flow

Creator